Evidence map›Paper›PMID 40593746›Full record

ArticleNature communications2025

Chiroptical switching and strong circularly polarized luminescence in peptide supramolecular assemblies.

Xin Li, Qingquan Han, Xianbao Li, Rui Li, Anhe Wang, Sen Liang, Yutao Sang, Jieling Li, Yajie Tian, Yang Yang and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Xin Li *State Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, China.
Qingquan Han *State Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, China.
Xianbao LiCAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing, 100190, China. lixb2022@nanoctr.cn.ORCID http://orcid.org/0000-0002-2821-8939
Rui LiState Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, China.
Anhe WangState Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, China.
Sen LiangState Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, China.ORCID http://orcid.org/0000-0001-8817-0562
Yutao SangState Key Laboratory of Molecular Engineering of Polymers, Department of Macromolecule Science, Fudan University, Shanghai, 200438, China.ORCID http://orcid.org/0000-0003-1170-7362
Jieling LiState Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, China.
Yajie TianState Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, China.
Yang YangCAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing, 100190, China.
Qi LiState Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, China. liqi@ipe.ac.cn.ORCID http://orcid.org/0000-0001-9764-4539
Shuo BaiState Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, China. baishuo@ipe.ac.cn.ORCID http://orcid.org/0000-0001-5360-3399
Junbai LiUniversity of Chinese Academy of Sciences, Beijing, 100049, China. jbli@iccas.ac.cn.ORCID http://orcid.org/0000-0001-9575-3125

Funding

China Postdoctoral Science Foundation 2023M730816National Natural Science Foundation of China (National Science Foundation of China) 22193031National Natural Science Foundation of China (National Science Foundation of China) 22193032National Natural Science Foundation of China (National Science Foundation of China) 22277121National Natural Science Foundation of China (National Science Foundation of China) 22307117National Natural Science Foundation of China (National Science Foundation of China) 22402040National Natural Science Foundation of China (National Science Foundation of China) 22407126Natural Science Foundation of Shandong Province (Shandong Provincial Natural Science Foundation) ZR2024QC163
6 · The paper itself

Abstract

Peptide-based materials offer unique advantages for constructing supramolecular chiral systems due to their bioactivity and intrinsic chirality. However, precise control over the expression, transfer, and amplification of chirality from the molecular to supramolecular level remains a significant challenge in developing high-performance chiral materials. In this study, we demonstrate that achiral anions regulate hydrogen bonding interactions in dipeptide assembly, leading to the formation of chiral microrolls composed of two-dimensional nanosheets. These microrolls exhibit pH-dependent chiroptical switching and intense circularly polarized luminescence with a dissymmetry factor (|g

Indexed as

DipeptidesLuminescencePeptidesCircular DichroismHydrogen BondingHydrogen-Ion ConcentrationNanostructuresStereoisomerismDipeptidesPeptides

Identifiers

PMID40593746
PMCPMC12217362

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.